|
ZNF397 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.881000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.094050E-02 |
| Normal-vs-Stage2 |
1.747800E-01 |
| Normal-vs-Stage3 |
2.614200E-02 |
| Normal-vs-Stage4 |
4.794400E-02 |
| Stage1-vs-Stage2 |
9.638800E-01 |
| Stage1-vs-Stage3 |
4.9320999999658E-06 |
| Stage1-vs-Stage4 |
7.99620000000445E-05 |
| Stage2-vs-Stage3 |
9.983300E-03 |
| Stage2-vs-Stage4 |
1.339820E-02 |
| Stage3-vs-Stage4 |
9.824000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.757200E-01 |
| Normal-vs-AfricanAmerican |
3.704200E-01 |
| Normal-vs-Asian |
6.154800E-01 |
| Caucasian-vs-AfricanAmerican |
4.803400E-01 |
| Caucasian-vs-Asian |
7.247600E-01 |
| AfricanAmerican-vs-Asian |
9.454400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.868400E-01 |
| Normal-vs-Female |
2.947600E-02 |
| Male-vs-Female |
7.380600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.138800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.463500E-02 |
| Normal-vs-Age(61-80Yrs) |
7.560200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.955400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.029610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.442200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.549200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.086500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.172200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.827000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.965000E-03 |
| Normal-vs-Grade 2 |
2.923600E-03 |
| Normal-vs-Grade 3 |
3.103600E-01 |
| Normal-vs-Grade 4 |
9.6980999999996E-05 |
| Grade 1-vs-Grade 2 |
1.493750E-02 |
| Grade 1-vs-Grade 3 |
5.63409999999598E-05 |
| Grade 1-vs-Grade 4 |
1.77519999811082E-08 |
| Grade 2-vs-Grade 3 |
1.164930E-04 |
| Grade 2-vs-Grade 4 |
6.17489948062655E-10 |
| Grade 3-vs-Grade 4 |
2.136300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.19719999997137E-06 |
| Normal-vs-ccB subtype |
2.784800E-03 |
| ccA subtype-vs-ccB subtype |
2.92765811593654E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.009200E-01 |
| Normal-vs-N1 |
1.806090E-04 |
| N0-vs-N1 |
1.403760E-04 |
|
|
